Clinical Trials
5 trialsNCT05415215 2026-02-10
ProHer
Hoffmann-La Roche
Phase 3 Completed
NCT05284591 2024-10-01
MYLENE
iOMEDICO AG
Completed
NCT05115006 2022-06-30
A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
Bristol-Myers Squibb
Completed
NCT02616692 2017-09-27
HCC Patient Preferences in Japan
Bayer
Completed
NCT01064310 2017-04-17
PISCES
Novartis
Phase 3 Completed